BridgeBio Oncology Therapeutics, Inc.
BBOT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001869105
No open-market purchases or sales by BridgeBio Oncology Therapeutics, Inc. insiders were filed in the last 90 days; 65 institutions reported holding it in 13F filings for Q2 2026, worth $450.6M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in BridgeBio Oncology Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −1 vs. Q4 2024
- Shares held
- 16.5M
- +42.2K (+0.3%) vs. Q4 2024
- Total value
- $186.3M
- +$13.6M (+7.9%) vs. Q4 2024
- New holders
- 3
- 9 more added
- Sold out
- 4
- 6 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BBOT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 65 | $450.6M |
| Q1 2026 | 67 | $513.8M |
| Q4 2025 | 52 | $724.7M |
| Q3 2025 | 42 | $657.5M |
| Q2 2025 | 34 | $177.6M |
| Q1 2025 | 31 | $186.3M |
| Q4 2024 | 32 | $172.7M |
| Q3 2024 | 31 | $171.1M |
| Q2 2024 | 31 | $167.4M |
| Q1 2024 | 29 | $166.9M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding BridgeBio Oncology Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 2,909,000 | $32.9M | 2.49% | 00.0% | Unchanged |
| BlackRock, Inc. | 1,498,865 | $16.9M | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,411,960 | $16.0M | 0.02% | +72,290+5.4% | Added |
| Adage Capital Partners GP, L.L.C. | 1,400,000 | $15.8M | 0.03% | 00.0% | Unchanged |
| Millennium Management LLC | 1,096,382 | $12.4M | 0.01% | −45,920−4.0% | Reduced |
| Price T Rowe Associates Inc | 1,071,550 | $12.1M | 0.00% | −16,221−1.5% | Reduced |
| Sculptor Capital LP | 800,000 | $9.04M | 0.20% | +95,000+13.5% | Added |
| Silverarc Capital Management, LLC | 613,393 | $6.93M | 1.45% | +100,024+19.5% | Added |
| Farallon Capital Management, L.L.C. | 600,000 | $6.78M | 0.04% | 00.0% | Unchanged |
| Harraden Circle Investments, LLC | 526,535 | $5.95M | 2.70% | +269,309+104.7% | Added |
| ADAR1 Capital Management, LLC | 469,729 | $5.31M | 1.02% | +65,591+16.2% | Added |
| Perceptive Advisors LLC | 398,000 | $4.50M | 0.16% | −102,000−20.4% | Reduced |
| T. Rowe Price Investment Management, Inc. | 397,962 | $4.50M | 0.00% | −2,285−0.6% | Reduced |
| Fort Baker Capital Management LP | 374,683 | $4.23M | 0.90% | +374,683 | New |
| Great Point Partners LLC | 373,833 | $4.22M | 2.30% | −126,167−25.2% | Reduced |
| Laurion Capital Management LP | 300,000 | $3.39M | 0.26% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 250,000 | $2.83M | 0.61% | 00.0% | Unchanged |
| Decagon Asset Management LLP | 239,403 | $2.71M | 2.45% | +52,949+28.4% | Added |
| StemPoint Capital LP | 200,900 | $2.27M | 0.73% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 189,285 | $2.14M | 0.00% | 00.0% | Unchanged |
| Acuta Capital Partners, LLC | 187,257 | $2.12M | 2.45% | +6,312+3.5% | Added |
| Wellington Management Group LLP | 184,590 | $2.09M | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 152,216 | $1.72M | 0.00% | +152,216 | New |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 150,000 | $1.70M | 0.03% | −325,114−68.4% | Reduced |
| TD Asset Management Inc | 144,772 | $1.64M | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 138,000 | $1.56M | 0.00% | +88,500+178.8% | Added |
| Woodline Partners LP | 103,247 | $1.17M | 0.01% | 00.0% | Unchanged |
| Moore Capital Management, LP | 100,000 | $1.13M | 0.04% | 00.0% | Unchanged |
| K2 Principal Fund, L.P. | 100,000 | $1.13M | 0.17% | +100,000 | New |
| UBS Group AG | 92,660 | $1.05M | 0.00% | +57,712+165.1% | Added |
| Geode Capital Management, LLC | 13,274 | $150.0K | 0.00% | 00.0% | Unchanged |
| Commodore Capital LP | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Gritstone Asset Management LLC | 0 | $0 | 0.00% | −24,666−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1−100.0% | Sold out |